Learn More
OBJECTIVE To devise new tools to assess activity and damage in patients with idiopathic myopathies (IIM). METHODS An international multidisciplinary consensus effort to standardize the conduct and(More)
PURPOSE A randomized phase III clinical trial of adjuvant active specific immunotherapy (ASI) with an autologous tumor cell-bacillus Calmette-Guérin (BCG) vaccine was conducted to determine whether(More)
PURPOSE The study contained herein was undertaken to evaluate the accuracy of radiolabeled human monoclonal antibody, 88BV59H21-2V67-66 (88BV59 or HumaSPECT-Tc), in predicting disease resectability(More)